Related Experiment Video
Updated: Oct 9, 2025

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
Published on: September 9, 2021
Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway
Rania Alaaeldin1, Iman A M Abdel-Rahman2, Heba Ali Hassan3
1Department of Biochemistry, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt.
Abstract:
Insulin resistance contributes to several disorders including type 2 diabetes and cardiovascular diseases. Carpachromene is a natural active compound that inhibits α-glucosidase enzyme. The aim of the present study is to investigate the potential activity of carpachromene on glucose consumption, metabolism and insulin signalling in a HepG2 cells insulin resistant model. A HepG2 insulin resistant cell model (HepG2/IRM) was established. Cell viability assay of HepG2/IRM cells was performed after carpachromene/metformin treatment. Glucose concentration and glycogen content were determined. Western blot analysis of insulin receptor, IRS1, IRS2, PI3k, Akt, GSK3, FoxO1 proteins after carpachromene treatment was performed. Phosphoenolpyruvate carboxykinase (PEPCK) and hexokinase (HK) enzymes activity was also estimated. Viability of HepG2/IRM cells was over 90% after carpachromene treatment at concentrations 6.3, 10, and 20 µg/mL. Treatment of HepG2/IRM cells with carpachromene decreased glucose concentration in a concentration- and time-dependant manner. In addition, carpachromene increased glycogen content of HepG2/IRM cells. Moreover, carpachromene treatment of HepG2/IRM cells significantly increased the expression of phosphorylated/total ratios of IR, IRS1, PI3K, Akt, GSK3, and FoxO1 proteins. Furthermore, PEPCK enzyme activity was significantly decreased, and HK enzyme activity was significantly increased after carpachromene treatment. The present study examined, for the first time, the potential antidiabetic activity of carpachromene on a biochemical and molecular basis. It increased the expression ratio of insulin receptor and IRS1 which further phosphorylated/activated PI3K/Akt pathway and phosphorylated/inhibited GSK3 and FoxO1 proteins. Our findings revealed that carpachromene showed central molecular regulation of glucose metabolism and insulin signalling via IR/IRS1/ PI3K/Akt/GSK3/FoxO1 pathway.
Insights
Carpachromene, a natural compound, enhances glucose metabolism and insulin signaling in liver cells. This study reveals its potential antidiabetic activity by improving insulin receptor function and key metabolic pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Insulin resistance is a key factor in type 2 diabetes and cardiovascular diseases.
- Carpachromene, a natural compound, is known to inhibit the alpha-glucosidase enzyme.
- Understanding carpachromene's effects on glucose metabolism and insulin signaling is crucial for developing new antidiabetic therapies.
Purpose of the Study:
- To investigate the effects of carpachromene on glucose consumption, metabolism, and insulin signaling.
- To establish and utilize a HepG2 cell model of insulin resistance (HepG2/IRM).
- To elucidate the molecular mechanisms underlying carpachromene's potential antidiabetic activity.
Main Methods:
- Established a HepG2 insulin resistant cell model (HepG2/IRM).
- Assessed cell viability, glucose concentration, and glycogen content following carpachromene treatment.
- Utilized Western blot analysis to examine key proteins in the insulin signaling pathway (IR, IRS1, PI3K, Akt, GSK3, FoxO1) and measured PEPCK and HK enzyme activities.
Main Results:
- Carpachromene treatment (6.3-20 µg/mL) showed over 90% cell viability in HepG2/IRM cells.
- Carpachromene significantly decreased glucose concentration and increased glycogen content in a dose- and time-dependent manner.
- Carpachromene enhanced insulin receptor signaling by increasing phosphorylated/total ratios of key proteins (IR, IRS1, PI3K, Akt, GSK3, FoxO1), decreased PEPCK activity, and increased HK activity.
Conclusions:
- Carpachromene demonstrates significant antidiabetic potential by improving glucose metabolism and insulin signaling in an in vitro model.
- The compound acts centrally on glucose metabolism and insulin signaling through the IR/IRS1/PI3K/Akt/GSK3/FoxO1 pathway.
- Carpachromene's ability to modulate key components of insulin signaling and glucose metabolism warrants further investigation for therapeutic applications.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression
Dipeptidyl Peptidase 4 Inhibitors
cAMP-dependent Protein Kinase Pathways

